Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Other Working Capital Changes (2016 - 2025)

Innospec's Other Working Capital Changes history spans 16 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 75.41% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $8.7 million, up 348.57%, while the annual FY2025 figure was $8.7 million, 348.57% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was $1.5 million at Innospec, down from $3.2 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $8.7 million in Q3 2022 and bottomed at -$5.3 million in Q2 2022.
  • The 5-year median for Other Working Capital Changes is -$50000.0 (2021), against an average of $205000.0.
  • The largest annual shift saw Other Working Capital Changes soared 1342.86% in 2022 before it plummeted 5400.0% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$200000.0 in 2021, then soared by 250.0% to $300000.0 in 2022, then plummeted by 533.33% to -$1.3 million in 2023, then skyrocketed by 569.23% to $6.1 million in 2024, then plummeted by 75.41% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for IOSP's Other Working Capital Changes are $1.5 million (Q4 2025), $3.2 million (Q3 2025), and $2.8 million (Q2 2025).